Logo
Logo
Cost Curve
LOGIN
SUBSCRIBE
Logo
Logo

Cost Curve

Everything drug pricing and policy, every day


Reuters Explores the Launch of CMS' Bridge Program, and Other Summer-Friday Highlights

Reuters Explores the Launch of CMS' Bridge Program, and Other Summer-Friday Highlights

It's a short Curve in hopes that you're enjoying a long weekend

Brian Reid
Brian Reid
Jul 24, 2026
Paid
Everyone Agrees: Trump’s Threatened Tariffs on Generic Drugs Are Going to Hike Prices and Create Shortages

Everyone Agrees: Trump’s Threatened Tariffs on Generic Drugs Are Going to Hike Prices and Create Shortages

And no one really thinks the tariff proposal is likely to achieve the goal of onshoring manufacturing, either

Brian Reid
Brian Reid
Jul 23, 2026
Paid
Drugmakers Lose a Battle -- But Make Progress in the War -- Over 340B Rebate Models

Drugmakers Lose a Battle -- But Make Progress in the War -- Over 340B Rebate Models

Plus Trump pledges 100% tariffs on generic meds ... but the tariffs wouldn’t kick in until his term is nearly over

Brian Reid
Brian Reid
Jul 22, 2026
Paid
The Media Strategy Behind a New Novo Lawsuit, J&J Weighs in on 340B, and a Deep Dive on the Biggest – But Most Invisible – Companies in Healthcare

The Media Strategy Behind a New Novo Lawsuit, J&J Weighs in on 340B, and a Deep Dive on the Biggest – But Most Invisible – Companies in Healthcare

Brian Reid
Brian Reid
Jul 21, 2026
Paid
Activity Around CMS’ GENEROUS and GUARD Models Is a Reminder That MFN Policy Never Takes a Vacation

Activity Around CMS’ GENEROUS and GUARD Models Is a Reminder That MFN Policy Never Takes a Vacation

Brian Reid
Brian Reid
Jul 20, 2026
Paid
Why Hospitals Escape Responsibility for Rising Health Costs, and Nine Other Stories for a Summer Friday

Why Hospitals Escape Responsibility for Rising Health Costs, and Nine Other Stories for a Summer Friday

Brian Reid
Brian Reid
Jul 17, 2026
Paid
The Implications of Merck’s Move to Price Its Cholesterol Pill at $315 a Month

The Implications of Merck’s Move to Price Its Cholesterol Pill at $315 a Month

And UnitedHealth Group’s revenues topped $100 billion -- again -- last quarter

Brian Reid
Brian Reid
Jul 16, 2026
Paid
CVS Caremark Settles Its FTC Insulin Lawsuit, Pledging Changes to the PBM Business Model

CVS Caremark Settles Its FTC Insulin Lawsuit, Pledging Changes to the PBM Business Model

Brian Reid
Brian Reid
Jul 15, 2026
Paid
The 340B Program Topped $100 Billion in Annual Sales Last Year; Big Hospitals Continue to Dominate

The 340B Program Topped $100 Billion in Annual Sales Last Year; Big Hospitals Continue to Dominate

Plus TrumpRx’s June site visits sunk to their lowest level since the site launched in February

Brian Reid
Brian Reid
Jul 14, 2026
Paid
arrow-down
Load More

Everything drug pricing and policy, every day.


© 2026 Brian Reid.
beehiivPowered by beehiiv